| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445652 | European Journal of Cancer | 2012 | 9 Pages |
Abstract
The combined treatment of bortezomib and CHOP is an effective and feasible regimen for advanced-stage PTCLs other than ENKTL, with acceptable toxicity. However, future studies exploring new drug combinations are warranted to overcome relapse after remission.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Jin Seok Kim, Seong Kyu Park, Hyo Jung Kim, Jeeyun Lee, Baek-Yeol Ryoo, Young Hyeh Ko, Jooryung Huh, Woo Ick Yang, Hee Kyung Kim, Soo Kee Min, Seung-Sook Lee, In-Gu Do, Cheolwon Suh, Won Seog Kim,